Mean arterial pressure for predicting preeclampsia in Asian women: a longitudinal cohort study

被引:10
作者
Zhu, Jing [1 ,2 ]
Zhang, Jun [1 ,3 ]
Syaza Razali, Nurul [3 ]
Chern, Bernard [3 ]
Tan, Kok Hian [3 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai Key Lab Childrens Environm Hlth,Minist E, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Obstet & Gynecol, Shanghai, Peoples R China
[3] KK Womens & Childrens Hosp, Div Obstet & Gynaecol, Singapore, Singapore
来源
BMJ OPEN | 2021年 / 11卷 / 08期
基金
英国医学研究理事会;
关键词
maternal medicine; hypertension; ultrasonography; BLOOD-PRESSURE; DOPPLER; PREGNANCY; ASSOCIATION; STATEMENT; RISK;
D O I
10.1136/bmjopen-2020-046161
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Previous studies suggested mean arterial pressure (MAP) had moderate predictive values in the first and second trimesters for the prediction of preeclampsia. However, the performance of MAP in Asian women is still unclear. The objective of this study was to examine the predictive values of MAP in Asian population throughout gestation, and to compare the performance of MAP, angiogenic factors and uterine artery Doppler in the prediction of preeclampsia. Design A prospective cohort study. Setting KK Women's and Children's Hospital, Singapore. Participants A total of 926 women with singleton pregnancy less than 14 weeks of gestation were included in the prospective Neonatal and Obstetrics Risks Assessment cohort between September 2010 and October 2014. Maternal blood pressure levels, uterine artery pulsatility index (UtA-PI), serum soluble fms-like tyrosine kinase 1 (sFlt-1), placental growth factor (PlGF) and sFlt-1/PlGF ratio were measured at 11-14, 18-22, 28-32 and 34 weeks onward, respectively. Primary and secondary outcomes Preeclampsia was the main pregnancy outcome. Results A total of 20 women developed preeclampsia, who had significantly lower levels of PlGF, higher levels of sFlt-1/PlGF ratio and MAP throughout pregnancy than women without preeclampsia. Compared with angiogenic factors and UtA-PI, MAP had significantly higher area under the receiver operating characteristic curves (AUCs) for predicting preeclampsia and term preeclampsia throughout gestation. For predicting preeclampsia, MAP had AUCs of 0.86 (95% CI 0.78 to 0.95), 0.87 (95% CI 0.80 to 0.95) and 0.91 (95% CI 0.85 to 0.98) at 11-14, 18-22 and 28-32 weeks, respectively. For predicting term preeclampsia, MAP yielded AUCs of 0.87 (95% CI 0.75 to 0.99), 0.87 (95% CI 0.76 to 0.98) and 0.90 (95% CI 0.80 to 0.99) at 11-14, 18-22 and 28-32 weeks, respectively. For predicting preterm preeclampsia, the performance of MAP and PlGF was similar. Conclusion MAP is a good predictor for preeclampsia, especially term preeclampsia, in Asian women.
引用
收藏
页数:9
相关论文
共 32 条
[11]   Longitudinal changes in uterine artery Doppler and blood pressure and risk of pre-eclampsia [J].
Khalil, A. ;
Garcia-Mandujano, R. ;
Maiz, N. ;
Elkhaouli, M. ;
Nicolaides, K. H. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2014, 43 (05) :541-547
[12]   A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia [J].
Kusanovic, Juan Pedro ;
Romero, Roberto ;
Chaiworapongsa, Tinnakorn ;
Erez, Offer ;
Mittal, Pooja ;
Vaisbuch, Edi ;
Mazaki-Tovi, Shali ;
Gotsch, Francesca ;
Edwin, Samuel S. ;
Gomez, Ricardo ;
Yeo, Lami ;
Conde-Agudelo, Agustin ;
Hassan, Sonia S. .
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2009, 22 (11) :1021-1038
[13]   Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: US Preventive Services Task Force Recommendation Statement [J].
LeFevre, Michael L. .
ANNALS OF INTERNAL MEDICINE, 2014, 161 (11) :819-U114
[14]   Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy [J].
McElrath, Thomas F. ;
Lim, Kee-Hak ;
Pare, Emmanuelle ;
Rich-Edwards, Janet ;
Pucci, Dominick ;
Troisi, Rebecca ;
Parry, Samuel .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2012, 207 (05) :407.e1-407.e7
[15]  
National Institute for Health and Clinical Excellence, 2019, HYPERTENSION PREGNAN
[16]  
Ng QJ., 2018, INT J GYNAECOL OBSTE, V4, P31
[17]   Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations [J].
O'Gorman, N. ;
Wright, D. ;
Poon, L. C. ;
Rolnik, D. L. ;
Syngelaki, A. ;
De Alvarado, M. ;
Carbone, I. F. ;
Dutemeyer, V. ;
Fiolna, M. ;
Frick, A. ;
Karagiotis, N. ;
Mastrodima, S. ;
Matallana, C. De Paco ;
Papaioannou, G. ;
Pazos, A. ;
Plasencia, W. ;
Nicolaides, K. H. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2017, 49 (06) :756-760
[18]   Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation [J].
O'Gorman, N. ;
Wright, D. ;
Poon, L. C. ;
Rolnik, D. L. ;
Syngelaki, A. ;
Wright, A. ;
Akolekar, R. ;
Cicero, S. ;
Janga, D. ;
Jani, J. ;
Molina, F. S. ;
Matallana, C. De Paco ;
Papantoniou, N. ;
Persico, N. ;
Plasencia, W. ;
Singh, M. ;
Nicolaides, K. H. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2017, 49 (06) :751-755
[19]   Uterine artery pulsatility index at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia [J].
O'Gorman, N. ;
Tampakoudis, G. ;
Wright, A. ;
Wright, D. ;
Nicolaides, K. H. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2016, 47 (05) :565-572
[20]   Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation [J].
O'Gorman, Neil ;
Wright, David ;
Syngelaki, Argyro ;
Akolekar, Ranjit ;
Wright, Alan ;
Poon, Leona C. ;
Nicolaides, Kypros H. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (01) :103.e1-103.e12